What is the recommended management of thumb carpometacarpal osteoarthritis in an adult over 50?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Thumb Carpometacarpal Osteoarthritis

Start with topical NSAIDs and thumb orthoses for initial management, escalate to intra-articular corticosteroid injections for painful flares, and reserve simple trapeziectomy alone for severe refractory cases—avoiding combined surgical procedures that increase complications without improving outcomes.

Stepwise Treatment Algorithm

First-Line Conservative Management

Topical NSAIDs are the preferred initial pharmacological treatment due to their favorable safety profile and efficacy 1. Topical diclofenac gel demonstrates small but significant improvements in pain and function after 8 weeks, with similar efficacy to oral NSAIDs but substantially fewer adverse effects 1. This is particularly important in adults over 50 who often have cardiovascular or gastrointestinal comorbidities.

Thumb orthoses should be prescribed for prolonged use (minimum 3 months) to achieve symptomatic benefit 1. The evidence supports:

  • Custom-made thermoplast long orthoses worn during activities of daily living, OR
  • Custom-made neoprene long orthoses worn at night
  • Short-term use (<3 months) shows no benefit; long-term adherence is essential 1

Exercise programs targeting the thumb base should focus on improving joint mobility, muscle strength, and CMC-1 stability 1. These differ from interphalangeal joint exercises and should be individualized by a hand therapist 2.

Second-Line Interventions

Intra-articular corticosteroid injections are recommended for painful flares, though evidence shows benefit primarily at one month, not sustained at 3,6, or 12 months 3. The 2007 EULAR guidelines note the supporting RCT was underpowered, and effectiveness relies substantially on expert opinion 3.

Intra-articular hyaluronan may provide more prolonged benefit than corticosteroids for trapeziometacarpal OA, with one RCT suggesting comparable pain relief but potentially longer duration of effect 3.

Oral NSAIDs should be considered for limited duration when multiple joints are affected or topical therapy proves insufficient 1. However, weigh cardiovascular and gastrointestinal risks carefully in this age group.

Surgical Management for Refractory Disease

When conservative treatments fail and patients have marked pain and/or disability, surgery becomes appropriate 3. The evidence strongly favors specific surgical approaches:

Simple trapeziectomy alone is the recommended surgical procedure based on the most recent high-quality evidence 4. A 2025 systematic review and network meta-analysis of 26 RCTs (1,193 hands) demonstrated:

  • Simple trapeziectomy ranked first for pain reduction
  • Demonstrated the most favorable complication profile
  • Alternative techniques showed relative increase in both number and severity of complications across all time periods (0-3 months, 3-12 months, and beyond 12 months; all P ≤ .03) 4

Avoid combined surgical procedures (trapeziectomy + ligament reconstruction and tendon interposition). The 2007 EULAR Cochrane review of 7 RCTs with 383 patients conclusively showed 3:

  • No better pain relief than simple trapeziectomy (ES = -0.17,95% CI -0.57 to 0.24)
  • No better functional improvement (ES = 0.03,95% CI -0.37 to 0.44)
  • More than double the complication rate (RR = 2.12,95% CI 1.24 to 3.60)
  • Complications include tendon rupture/adhesion, scar tenderness, sensory changes, neurological complications, instability, and complex regional pain syndrome

Total joint replacement showed no advantage over combined approaches and should similarly be avoided 3.

Critical Pitfalls to Avoid

  1. Prescribing short-duration orthosis use: Benefits only manifest after ≥3 months of consistent wear 1

  2. Relying on intra-articular corticosteroids for long-term management: Effects diminish after one month 3

  3. Performing combined surgical procedures: The evidence unequivocally demonstrates increased complications without improved outcomes 3, 4

  4. Prescribing poorly-fitted orthoses: Custom-made orthoses by specialized hand therapists improve compliance and long-term use 1

  5. Using oral NSAIDs as first-line therapy: Topical formulations provide comparable efficacy with superior safety profiles in this age group 1

Evidence Quality Considerations

The 2019 ACR/Arthritis Foundation guidelines provide strong recommendations for hand orthoses for first CMC joint OA 5, while the 2018 EULAR update offers more granular guidance on orthosis type and duration 1. The most recent surgical evidence from 2025 4 supersedes earlier recommendations, definitively establishing simple trapeziectomy as superior to alternative techniques through network meta-analysis—the highest level of comparative effectiveness evidence available.

Related Questions

For carpometacarpal (CMC) arthritis, is a short thumb‑spica splint sufficient or is a long thumb‑spica splint needed?
What is the appropriate evaluation and treatment for a patient who underwent carpal tunnel release two years ago and now presents with pain in the thumb carpometacarpal (CMC) joint?
In a 75-year-old patient with pain at the base of the thumb that worsens with key turning, folding laundry, and gripping, what is the most likely diagnosis?
What diagnostic testing and imaging should be performed for suspected thumb arthritis?
Given degenerative changes with mild fragmentation of the first carpometacarpal (thumb base) joint and no acute fracture or dislocation, should the patient be referred to a hand specialist?
In a 45-year-old woman who has had a hysterectomy with intact ovaries, how should perimenopausal symptoms be treated?
What are the appropriate dosing guidelines, contraindications, precautions, and common adverse effects of benzonatate for adults and children?
What is the appropriate management for a total cholesterol of 482 mg/dL?
Can patients with known cardiac disease such as arrhythmias, heart failure, or ischemic heart disease safely use Tessalon (benzonatate)?
What are the types and characteristics of the Salter‑Harris classification of pediatric growth‑plate fractures?
What is the recommended diagnostic approach and empiric antibiotic regimen for infective endocarditis in an adult with native‑valve disease, no known penicillin allergy, and no recent healthcare exposure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.